FDA issued an advance notice of proposed rulemaking on Friday (March 23) seeking input on whether and how it should regulate premium cigars, despite the agency's apparent skepticism over the quality of data it received the last time it made a similar request to stakeholders. The agency is seeking more solid research on the use patterns and public health impacts of premium cigars and non-premium cigars, and input on what should be considered a premium cigar. In response to the...